Visby Collaborates with Urgent Care Leaders in Scottsdale, AZ

Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.

14th Annual ConvUrgent Care Symposium

September 6-9, 2022

Hotel Valley Ho
6850 East Main Street
Scottsdale, AZ 85251

The annual ConvUrgent Care Symposium is an opportunity for healthcare leaders to collaborate on the consumerization of medical care and a wonderful reason for Team Visby to pack it up and head down south.

Visit our booth to hold our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

Learn more about the Visby Medical Sexual Health Test

04/05/2024 • Viewpoint

The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

In light of the rising rates of sexually transmitted infections (STIs), urgent care clinics have found themselves at a crucial crossroads. PCR (Polymerase Chain Reaction) testing at the point of care emerges as a potential game-changer.

03/14/2024 • Viewpoint

Understanding the Financial Impact of PCR Point of Care Testing for STIs

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in diagnostic capabilities. With its promise of speed, accuracy, and efficiency, PCR testing technology is setting a new standard in patient care.

03/07/2024 • Viewpoint

5 Frequently Asked Questions on Implementing PCR into Urgent Care

02/21/2024 • Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.